Patent details

EP1309618 Title: LEUCINE-BASED MOTIF AND CLOSTRIDIAL NEUROTOXINS

Basic Information

Publication number:
EP1309618
PCT Application Number:
PCT/US/2001/023122
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP019591155
PCT Publication Number:
WO/2002/008268
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
LEUCINE-BASED MOTIF AND CLOSTRIDIAL NEUROTOXINS
French Title of Invention:
MOTIF A BASE DE LEUCINE ET NEUROTOXINES CLOSTRIDIALES
German Title of Invention:
MOTIF AUF BASIS VAN LEUCIN UND CLOSTRIDIUM NEUROTOXINE
SPC Number:

Dates

Filing date:
20/07/2001
Grant date:
12/12/2007
EP Publication Date:
12/12/2007
PCT Publication Date:
31/01/2002
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/05/2003
EP B1 Publication Date:
12/12/2007
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
20/07/2021
Renunciation date:
Revocation date:
20/07/2008
Annulment date:

Owner

From:
17/03/2008
 
 

Name:
ALLERGAN INC.
Address:
2525 Dupont Drive, Irvine, CA 92612, United States (US)

Inventor

1

Name:
FERNANDEZ-SALAS Ester
Address:
United States (US)

2

Name:
STEWARD Lance, E.
Address:
United States (US)

3

Name:
HERRINGTON Todd, M.
Address:
United States (US)

4

Name:
AOKI Kei, Roger
Address:
United States (US)

Priority

Priority Number:
620840
Priority Date:
21/07/2000
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 14/33;
Filing date Document type Number of pages